Skip to main content

8 Result(s)

within M V Cronauer Remove this filter

and

  1. Article

    Open Access

    Mutant PIK3CA controls DUSP1-dependent ERK 1/2 activity to confer response to AKT target therapy

    Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel ...

    A Sathe, F Guerth, M V Cronauer, M M Heck, M Thalgott… in British Journal of Cancer (2014)

    Download PDF (1887 KB) View Article

  2. Article

    Molecular aspects of prostate cancer

    M. V. Cronauer, Z. Culig in World Journal of Urology (2012)

    Download PDF (140 KB) View Article

  3. No Access

    Article

    [11C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy

    To evaluate [11C]choline positron emission tomography/computed tomography ([11C]choline PET/CT) for the detection of a biochemical recurrence of prostate cancer after radical prostatectomy.

    Ludwig Rinnab, Joerg Simon, Richard E. Hautmann, M. V. Cronauer… in World Journal of Urology (2009)

  4. No Access

    Article

    Die Rolle des Androgenrezeptors im hormonrefraktären Prostatakarzinom

    Die Entstehung hormonrefraktärer Prostatakarzinomzellen während einer Hormonablationstherapie stellt die Hauptursache für den Tumorprogress und die hohe Mortalitätsrate des fortgeschrittenen Prostatakarzinoms ...

    Dr. L. Rinnab, A. Hessenauer, S.V. Schütz, E. Schmid, R. Küfer, F. Finter… in Der Urologe (2008)

  5. No Access

    Article

    Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression

    Chronic inflammation increases the risk of cancer and many cancers, including prostate cancer, arise at sites of chronic inflammation. Inducible nitric oxide synthase (iNOS) is an enzyme dominantly expressed d...

    M V Cronauer, Y Ince, R Engers, L Rinnab, W Weidemann, C V Suschek, M Burchardt… in Oncogene (2007)

  6. Article

    Open Access

    Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells

    Interactions between polypeptide growth factors and the androgen receptor (AR) are important for regulation of cellular events in carcinoma of the prostate. Basic fibroblast growth factor (bFGF), the prototype...

    M V Cronauer, C Nessler-Menardi, H Klocker, K Maly, A Hobisch… in British Journal of Cancer (2000)

    Download PDF (405 KB)

  7. No Access

    Article

    Activation of the androgen receptor by polypeptide growth factors and cellular regulators

    The polypeptide growth factors insulin-like growth factor I (IGF-I), epidermal growth factor (EGF), and transforming growth factor-α (TGF-α); second-messenger cyclic adenosine monophosphate (cAMP); protein kin...

    Z. Culig, A. Hobisch, M. V. Cronauer, A. Hittmair, C. Radmayr… in World Journal of Urology (1995)

  8. No Access

    Chapter

    Die Bedeutung des Onkogens HER 2 beim Ovarialkarzinom

    Die Zellproliferation wird wesentlich durch zwei sich antagonisierende Gengruppen bestimmt. Dies sind zum einen die mit einer Wachstumshemmung einhergehenden Tumorsuppressorgene und zum anderen die mit einer W...

    Ch. Marth, A. G. Zeimet, E. Müller-Holzner, J. Schatzer… in Das Ovarialkarzinom (1993)